PCN64 COST-EFFECTIVENESS OF CABOZANTINIB FOR PATIENTS WITH...

Value in Health 2019 / 05 Vol. 22

PCN64 COST-EFFECTIVENESS OF CABOZANTINIB FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA AFTER FAILURE OF PRIOR THERAPY IN BRAZIL

Serafini, P., Stefani, S., Nebel de Mello, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.188
Date:
May, 2019
File:
PDF, 382 KB
english, 2019
Conversion to is in progress
Conversion to is failed